QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||
For the quarterly period ended | ||
OR | ||
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||
For the transition period | from ________ to ________ | |
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) | ||
(Address of Principal Executive Offices) | (Zip Code) | ||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Nasdaq Texas, LLC | ||||
☒ | Accelerated filer | ☐ | |
Non-accelerated filer | ☐ | Smaller reporting company | |
Emerging growth company |
Class | Outstanding at April 16, 2026 | ||
Common Stock, $0.01 par value per share | shares | ||
TABLE OF CONTENTS | |||
PART I | |||
Item 1. | |||
Item 2. | |||
Item 3. | |||
Item 4. | |||
PART II | |||
Item 1. | |||
Item 1A. | |||
Item 2. | |||
Item 5. | |||
Item 6. | |||
March 31, 2026 | December 31, 2025 | ||
(unaudited) | |||
Assets | |||
Current assets: | |||
Cash and cash equivalents | $ | $ | |
Restricted cash and cash equivalents | |||
Default funds and margin deposits (including restricted cash and cash equivalents of $ | |||
Financial investments | |||
Receivables, net | |||
Other current assets | |||
Total current assets | |||
Property and equipment, net | |||
Goodwill | |||
Intangible assets, net | |||
Operating lease assets | |||
Other non-current assets | |||
Total assets | $ | $ | |
Liabilities | |||
Current liabilities: | |||
Accounts payable and accrued expenses | $ | $ | |
Accrued personnel costs | |||
Deferred revenue | |||
Other current liabilities | |||
Default funds and margin deposits | |||
Short-term debt | |||
Total current liabilities | |||
Long-term debt | |||
Deferred tax liabilities, net | |||
Operating lease liabilities | |||
Other non-current liabilities | |||
Total liabilities | |||
Commitments and contingencies | |||
Equity | |||
Nasdaq stockholders’ equity: | |||
Common stock, $ outstanding: | |||
Additional paid-in capital | |||
Common stock in treasury, at cost: shares at December 31, 2025 | ( | ( | |
Accumulated other comprehensive loss | ( | ( | |
Retained earnings | |||
Total Nasdaq stockholders’ equity | |||
Noncontrolling interests | |||
Total equity | |||
Total liabilities and equity | $ | $ |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Revenues: | |||
Capital Access Platforms | $ | $ | |
Financial Technology | |||
Market Services | |||
Other revenues | |||
Total revenues | |||
Transaction-based expenses: | |||
Transaction rebates | ( | ( | |
Brokerage, clearance and exchange fees | ( | ( | |
Revenues less transaction-based expenses | |||
Operating expenses: | |||
Compensation and benefits | |||
Professional and contract services | |||
Technology and communication infrastructure | |||
Occupancy | |||
General, administrative and other | |||
Marketing and advertising | |||
Depreciation and amortization | |||
Regulatory | |||
Merger and strategic initiatives | |||
Restructuring charges | |||
Total operating expenses | |||
Operating income | |||
Interest income | |||
Interest expense | ( | ( | |
Net gain on divestitures | |||
Other losses | ( | ( | |
Net income from unconsolidated investees | |||
Income before income taxes | |||
Income tax provision | |||
Net income | $ | $ | |
Per share information: | |||
Basic earnings per share | $ | $ | |
Diluted earnings per share | $ | $ | |
Cash dividends declared per common share | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Net income | $ | $ | |
Other comprehensive income (loss): | |||
Foreign currency translation gains (losses) | ( | ||
Income tax benefit (expense)(1) | ( | ||
Foreign currency translation, net | ( | ||
Unrealized gain (loss) on derivatives instruments, net | ( | ||
Total other comprehensive income (loss), net of tax | ( | ||
Comprehensive income | $ | $ | |
Three Months Ended March 31, | |||||||
2026 | 2025 | ||||||
Shares | $ | Shares | $ | ||||
Common stock | |||||||
Additional paid-in capital | |||||||
Beginning balance | |||||||
Share repurchase program | ( | ( | ( | ( | |||
Share-based compensation | |||||||
Issuance of stock under employee stock plans | — | ||||||
Ending balance | |||||||
Common stock in treasury, at cost | |||||||
Beginning balance | ( | ( | |||||
Employee shares withheld | ( | ( | ( | ( | |||
Ending balance | ( | ( | |||||
Accumulated other comprehensive loss | |||||||
Beginning balance | ( | ( | |||||
Other comprehensive income (loss) | ( | ||||||
Ending balance | ( | ( | |||||
Retained earnings | |||||||
Beginning balance | |||||||
Net income | |||||||
Cash dividends declared and paid | ( | ( | |||||
Ending balance | |||||||
Total Nasdaq stockholders’ equity | |||||||
Noncontrolling interests | |||||||
Beginning balance | |||||||
Net activity related to noncontrolling interests | — | — | |||||
Ending balance | |||||||
Total Equity | $ | $ | |||||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Cash flows from operating activities: | |||
Net income | $ | $ | |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Depreciation and amortization | |||
Share-based compensation | |||
Deferred income tax expense | |||
Net gain on divestitures | ( | ||
Net income from unconsolidated investees | ( | ( | |
Other reconciling items included in net income | ( | ||
Net change in operating assets and liabilities, excluding the effects of divestitures: | |||
Receivables, net | ( | ||
Other assets | |||
Accounts payable and accrued expenses | ( | ( | |
Section 31 fees payable to SEC | ( | ||
Accrued personnel costs | ( | ( | |
Deferred revenue | |||
Other liabilities | ( | ( | |
Net cash provided by operating activities | |||
Cash flows from investing activities: | |||
Purchases of securities | ( | ( | |
Proceeds from sales and redemptions of securities | |||
Purchases of property and equipment | ( | ( | |
Investments related to default funds and margin deposits, net(1) | ( | ||
Other investing activities | ( | ( | |
Net cash provided by (used in) investing activities | ( | ||
Cash flows from financing activities: | |||
Repayments of debt and credit commitment | ( | ||
Repurchases of common stock | ( | ( | |
Dividends paid | ( | ( | |
Proceeds from issuance of stock under employee stock plans | |||
Payments related to employee shares withheld for taxes | ( | ( | |
Default funds and margin deposits | ( | ( | |
Other financing activities | |||
Net cash used in financing activities | ( | ( | |
Effect of exchange rate changes on cash and cash equivalents and restricted cash and cash equivalents | ( | ||
Net decrease in cash and cash equivalents and restricted cash and cash equivalents | ( | ( | |
Cash and cash equivalents, restricted cash and cash equivalents at beginning of period | |||
Cash and cash equivalents, restricted cash and cash equivalents at end of period | $ | $ | |
Reconciliation of Cash, Cash Equivalents and Restricted Cash and Cash Equivalents | |||
Cash and cash equivalents | $ | $ | |
Restricted cash and cash equivalents | |||
Restricted cash and cash equivalents (default funds and margin deposits) | |||
Total | $ | $ | |
Supplemental Disclosure - Cash Flow Information | |||
Cash paid for: | |||
Interest paid | $ | $ | |
Income taxes paid, net of refunds | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(in millions) | |||
Capital Access Platforms | |||
Data & Listing Services | $ | $ | |
Index | |||
Workflow & Insights | |||
Financial Technology | |||
Financial Crime Management Technology | |||
Regulatory Technology | |||
Capital Markets Technology | |||
Market Services, net | |||
Other revenues | |||
Revenues less transaction-based expenses | $ | $ | |
Financial Crime Management Technology | Regulatory Technology | Capital Markets Technology | Workflow & Insights | Total | |||||
(in millions) | |||||||||
Remainder of 2026 | $ | $ | $ | $ | $ | ||||
2027 | |||||||||
2028 | |||||||||
2029 | |||||||||
2030 | |||||||||
2031+ | |||||||||
Total | $ | $ | $ | $ | $ | ||||
(in millions) | |
Capital Access Platforms | |
Balance at December 31, 2025 | $ |
Foreign currency translation adjustments | ( |
Balance at March 31, 2026 | $ |
Financial Technology | |
Balance at December 31, 2025 | $ |
Foreign currency translation adjustments | ( |
Balance at March 31, 2026 | $ |
Market Services | |
Balance at December 31, 2025 | $ |
Foreign currency translation adjustments | ( |
Balance at March 31, 2026 | $ |
Total | |
Balance at December 31, 2025 | $ |
Foreign currency translation adjustments | ( |
Balance at March 31, 2026 | $ |
March 31, 2026 | December 31, 2025 | ||
Finite-Lived Intangible Assets | (in millions) | ||
Gross Amount: | |||
Technology | $ | $ | |
Customer relationships | |||
Trade names and other | |||
Foreign currency translation adjustment | ( | ( | |
Total gross amount | $ | $ | |
Accumulated Amortization: | |||
Technology | $( | $( | |
Customer relationships | ( | ( | |
Trade names and other | ( | ( | |
Foreign currency translation adjustment | |||
Total accumulated amortization | $( | $( | |
Net Amount: | |||
Technology | $ | $ | |
Customer relationships | |||
Trade names and other | |||
Foreign currency translation adjustment | ( | ( | |
Total finite-lived intangible assets | $ | $ | |
Indefinite-Lived Intangible Assets | |||
Exchange and clearing registrations | $ | $ | |
Trade names | |||
Licenses | |||
Foreign currency translation adjustment | ( | ( | |
Total indefinite-lived intangible assets | $ | $ | |
Total intangible assets, net | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(in millions) | |||
Amortization expense | $ | $ | |
(in millions) | |
Remainder of 2026 | $ |
2027 | |
2028 | |
2029 | |
2030 | |
2031+ | |
Total | $ |
March 31, 2026 | December 31, 2025 | ||
(in millions) | |||
Financial investments | $ | $ | |
Equity method investments | |||
Equity securities | |||
Balance at December 31, 2025 | Additions | Revenue Recognized | Foreign Currency Translation | Balance at March 31, 2026 | |
Capital Access Platforms: | (in millions) | ||||
Initial Listings | $ | $ | $( | $ | $ |
Annual Listings | ( | ( | |||
Workflow & Insights | ( | ( | |||
Other | ( | ||||
Financial Technology: | |||||
Financial Crime Management Technology | ( | ||||
Regulatory Technology | ( | ||||
Capital Markets Technology | ( | ( | |||
Total | $ | $ | $( | $( | $ |
Fiscal year ended: | 2026 | 2027 | 2028 | 2029 | 2030 | 2031+ | Total |
Capital Access Platforms: | (in millions) | ||||||
Initial Listings | $ | $ | $ | $ | $ | $ | $ |
Annual Listings | |||||||
Workflow & Insights | |||||||
Other | |||||||
Financial Technology: | |||||||
Financial Crime Management Technology | |||||||
Regulatory Technology | |||||||
Capital Markets Technology | |||||||
Total | $ | $ | $ | $ | $ | $ | $ |
December 31, 2025 | Payments, Foreign Currency Translation and Accretion | March 31, 2026 | |||
Short-term debt: | (in millions) | ||||
2026 Notes | $ | $ | $ | ||
Total short-term debt | $ | $ | $ | ||
Long-term debt - senior unsecured notes: | |||||
2028 Notes | |||||
2029 Notes | ( | ||||
2030 Notes | ( | ||||
2031 Notes | |||||
2032 Notes | ( | ||||
2033 Notes | ( | ||||
2034 Notes | |||||
2040 Notes | |||||
2050 Notes | |||||
2052 Notes | |||||
2053 Notes | |||||
2063 Notes | |||||
2022 Revolving Credit Facility | ( | ( | |||
Total long-term debt | $ | $( | $ | ||
Total debt obligations | $ | $( | $ | ||
Three Months Ended March 31, | |||
2026 | 2025 | ||
(in millions) | |||
Savings Plan expense | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(in millions) | |||
Retirement Plans expense | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(in millions) | |||
Share-based compensation expense before income taxes | $ | $ | |
Restricted Stock | |||
Number of Awards | Weighted-Average Grant Date Fair Value | ||
Unvested at December 31, 2025 | $ | ||
Granted | |||
Vested | ( | ||
Forfeited | ( | ||
Unvested at March 31, 2026 | $ | ||
PSUs | ||||
Number of Awards | Weighted- Average Grant Date Fair Value | |||
Unvested at December 31, 2025 | $ | |||
Granted | ||||
Vested | ( | |||
Forfeited | ( | |||
Unvested at March 31, 2026 | $ | |||
Number of Stock Options | Weighted- Average Exercise Price | Weighted- Average Remaining Contractual Term (in years) | Aggregate Intrinsic Value (in millions) | |
Outstanding at December 31, 2025 | $ | |||
Exercised | ( | |||
Outstanding at March 31, 2026 | $ | $ | ||
Exercisable at March 31, 2026 | $ | $ |
Three Months Ended March 31, 2026 | |
Number of shares of common stock repurchased | |
Average price paid per share | $ |
Total purchase price (in millions) | $ |
Declaration Date | Dividend Per Common Share | Record Date | Total Amount Paid | Payment Date | ||||
(in millions) | ||||||||
January 28, 2026 | $ | March 16, 2026 | $ | March 30, 2026 | ||||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Numerator: | (in millions, except share and per share amounts) | ||
Net income | $ | $ | |
Denominator: | |||
Weighted-average common shares outstanding for basic earnings per share | |||
Weighted-average effect of dilutive securities - Employee equity awards | |||
Weighted-average common shares outstanding for diluted earnings per share | |||
Basic and diluted earnings per share: | |||
Basic earnings per share | $ | $ | |
Diluted earnings per share | $ | $ | |
March 31, 2026 | |||||||
Total | Level 1 | Level 2 | Level 3 | ||||
(in millions) | |||||||
European government debt securities | $ | $ | $ | $ | |||
State-owned enterprises and municipal securities | |||||||
Total financial investments | $ | $ | $ | $ | |||
Equity securities | |||||||
Total assets at fair value | $ | $ | $ | $ | |||
December 31, 2025 | |||||||
Total | Level 1 | Level 2 | Level 3 | ||||
(in millions) | |||||||
European government debt securities | $ | $ | $ | $ | |||
Total financial investments | $ | $ | $ | $ | |||
Equity securities | |||||||
Total assets at fair value | $ | $ | $ | $ | |||
March 31, 2026 | |||||
Cash Contributions | Non-Cash Contributions | Total Contributions | |||
(in millions) | |||||
Default fund contributions | $ | $ | $ | ||
Margin deposits | |||||
Total | $ | $ | $ | ||
March 31, 2026 | December 31, 2025 | ||
(in millions) | |||
Demand deposits | $ | $ | |
Central bank certificates | |||
Restricted cash and cash equivalents | $ | $ | |
European government debt securities | |||
Reverse repurchase agreements | |||
Multilateral development bank debt securities | |||
Investments | $ | $ | |
Total | $ | $ | |
March 31, 2026 | |
(in millions) | |
Commodity forwards | $ |
Fixed-income swaps and forwards | |
Stock options and forwards | |
Index options and forwards | |
Total | $ |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Commodity futures and forwards | |||
Fixed-income swaps, futures and forwards | |||
Stock options, futures and forwards | |||
Index options, futures and forwards | |||
Total | |||
Balance Sheet Classification | March 31, 2026 | December 31, 2025 | ||||
Assets: | (in millions) | |||||
Operating lease assets | Operating lease assets | $ | $ | |||
Liabilities: | ||||||
Current lease liabilities | Other current liabilities | $ | $ | |||
Non- current lease liabilities | Operating lease liabilities | |||||
Total lease liabilities | $ | $ | ||||
Three Months Ended March 31, | |||
2026 | 2025 | ||
(in millions) | |||
Operating lease cost | $ | $ | |
Variable lease cost | |||
Sublease income | ( | ( | |
Total lease cost | $ | $ | |
March 31, 2026 | ||
(in millions) | ||
Remainder of 2026 | $ | |
2027 | ||
2028 | ||
2029 | ||
2030 | ||
2031+ | ||
Total lease payments | $ | |
Less: interest | ( | |
Present value of lease liabilities | $ |
March 31, 2026 | ||
Weighted-average remaining lease term (in years) | ||
Weighted-average discount rate |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(in millions) | |||
Cash paid for amounts included in the measurement of operating lease liabilities | $ | $ | |
Lease assets obtained in exchange for operating lease liabilities | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(in millions) | |||
Income tax provision | $ | $ | |
Effective tax rate | |||
Capital Access Platforms | Financial Technology | Market Services | Corporate | Total | |
March 31, 2026 | (in millions) | ||||
Total revenues | $ | $ | $ | $ | $ |
Transaction- based expenses | — | — | ( | — | ( |
Revenues less transaction- based expenses | |||||
Directly consumed expenses | — | ||||
Other expenses | |||||
Operating income | $ | $ | $ | $( | $ |
Depreciation and amortization | |||||
Purchases of property and equipment | — | ||||
Capital Access Platforms | Financial Technology | Market Services | Corporate | Total | |
March 31, 2025 | |||||
Total revenues | $ | $ | $ | $ | $ |
Transaction- based expenses | — | — | ( | — | ( |
Revenues less transaction- based expenses | |||||
Directly consumed expenses | — | ||||
Other expenses | |||||
Operating income | $ | $ | $ | $( | $ |
Depreciation and amortization | |||||
Purchases of property and equipment | — | ||||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Revenues: | (in millions) | ||
Divestitures of businesses | $ | $ | |
Expenses: | |||
Amortization expense of acquired intangible assets | |||
Merger and strategic initiatives expense | |||
Restructuring charges | |||
Legal and regulatory matters | |||
Gain on extinguishment of debt | ( | ||
Expenses - divestitures | |||
Other | |||
Total expenses | $ | $ | |
Operating loss | $( | $( | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(in millions) | |||
United States | $ | $ | |
All other countries | |||
Total | $ | $ | |
(in millions) | March 31, 2026 | December 31, 2025 | |
United States | $ | $ | |
All other countries | |||
Total | $ | $ |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(in millions) | |||
Consulting services | $ | $ | |
Employee-related costs | |||
Other | |||
Total restructuring charges | $ | $ | |
Three Months Ended March 31, | Percentage Change | ||||
2026 | 2025 | ||||
(in millions, except per share amounts) | |||||
Revenues less transaction-based expenses | $1,407 | $1,237 | 13.8% | ||
Operating expenses | 750 | 690 | 8.8% | ||
Operating income | $657 | $547 | 20.1% | ||
Net income | $519 | $395 | 31.4% | ||
Diluted earnings per share | $0.91 | $0.68 | 33.3% | ||
Cash dividends declared per common share | $0.27 | $0.24 | 12.5% | ||

▪ | Capital Access Platforms | |
◦ | Proprietary market data subscriptions and annual listing fees within our Data & Listing Services business | |
◦ | Index data subscriptions and guaranteed minimum on futures contracts within our Index business | |
◦ | Subscription contracts under our Workflow & Insights business | |
▪ | Financial Technology | |
◦ | Subscription contracts excluding non-recurring professional services. | |
▪ | Other includes ARR related to our Solovis business divested in October 2025. | |

Three Months Ended March 31, | Percentage Change | ||||
2026 | 2025 | ||||
(in millions) | |||||
Capital Access Platforms | $565 | $508 | 11.4% | ||
Financial Technology | 517 | 432 | 19.7% | ||
Market Services | 1,047 | 1,140 | (8.1)% | ||
Other revenues | 8 | 16 | (50.6)% | ||
Total revenues | $2,137 | $2,096 | 2.0% | ||
Transaction rebates | (724) | (585) | 23.9% | ||
Brokerage, clearance and exchange fees | (6) | (274) | (97.9)% | ||
Total revenues less transaction-based expenses | $1,407 | $1,237 | 13.8% | ||

Three Months Ended March 31, | Percentage Change | ||||
2026 | 2025 | ||||
(in millions) | |||||
Data & Listing Services | $214 | $192 | 11.4% | ||
Index | 220 | 193 | 14.4% | ||
Workflow & Insights | 131 | 123 | 6.7% | ||
Total Capital Access Platforms | $565 | $508 | 11.4% | ||
As of March 31, | ||||
2026 | 2025 | |||
ARR (in millions) | $1,366 | $1,252 | ||
Three Months Ended March 31, | |||
IPOs | 2026 | 2025 | |
The Nasdaq Stock Market | 63 | 63 | |
Operating company | 15 | 45 | |
SPACs | 48 | 18 | |
Exchanges that comprise Nasdaq Nordic and Nasdaq Baltic | — | 4 | |
Total new listings | |||
The Nasdaq Stock Market | 176 | 170 | |
Exchanges that comprise Nasdaq Nordic and Nasdaq Baltic | 5 | 9 | |
As of December 31 | |||
Number of listed companies | 2026 | 2025 | |
The Nasdaq Stock Market | 4,570 | 4,139 | |
Exchanges that comprise Nasdaq Nordic and Nasdaq Baltic | 1,107 | 1,160 | |
ARR (in millions) | $777 | $701 | |
As of or Three Months Ended March 31, | ||||
2026 | 2025 | |||
Number of licensed ETPs | 470 | 418 | ||
TTM change in period end ETP AUM tracking Nasdaq indices (in billions) | ||||
Beginning balance | $622 | $519 | ||
Net appreciation | 135 | 17 | ||
Net inflows | 79 | 86 | ||
Ending balance | $836 | $622 | ||
Quarterly average ETP AUM tracking Nasdaq indices (in billions) | $877 | $662 | ||
ARR (in millions) | $85 | $79 | ||
As of or Three Months Ended March 31, | |||
2026 | 2025 | ||
(in millions) | |||
ARR | $504 | $472 | |
Quarterly annualized SaaS revenues | 432 | 401 | |
Three Months Ended March 31, | Percentage Change | ||||
2026 | 2025 | ||||
(in millions) | |||||
Financial Crime Management Technology | $93 | $77 | 21.0% | ||
Regulatory Technology | 118 | 101 | 16.4% | ||
Capital Markets Technology | 306 | 254 | 20.6% | ||
Total Financial Technology | $517 | $432 | 19.7% | ||
As of or Three Months Ended March 31, | ||||
2026 | 2025 | |||
(in millions) | ||||
ARR and Quarterly annualized SaaS revenues | $344 | $295 | ||
As of or Three Months Ended March 31, | ||||
2026 | 2025 | |||
(in millions) | ||||
ARR | $419 | $362 | ||
Quarterly annualized SaaS revenues | 252 | 197 | ||
As of or Three Months Ended March 31, | |||
2026 | 2025 | ||
(in millions) | |||
ARR | $1,059 | $893 | |
Quarterly annualized SaaS revenues | 174 | 139 | |
Three Months Ended March 31, | Percentage Change | ||||
2026 | 2025 | ||||
(in millions) | |||||
Market Services | $1,047 | $1,140 | (8.1)% | ||
Transaction-based expenses: | |||||
Transaction rebates | (724) | (585) | 23.9% | ||
Brokerage, clearance and exchange fees | (6) | (274) | (97.9)% | ||
Total Market Services, net | $317 | $281 | 12.8% | ||
Three Months Ended March 31, | Percentage Change | ||||
2026 | 2025 | ||||
(in millions) | |||||
U.S. Equity Derivative Trading | $120 | $108 | 10.7% | ||
Cash Equity Trading | 138 | 121 | 14.8% | ||
U.S. Tape plans | 33 | 33 | 1.5% | ||
Other | 26 | 19 | 30.7% | ||
Total Market Services, net | $317 | $281 | 12.8% | ||
Three Months Ended March 31, | Percentage Change | ||||
2026 | 2025 | ||||
(in millions) | |||||
U.S. Equity Derivative Trading Revenues | $432 | $409 | 7.3% | ||
Section 31 fees | — | 32 | (100.0)% | ||
Transaction-based expenses: | |||||
Transaction rebates | (312) | (299) | 6.4% | ||
Section 31 fees | — | (32) | (100.0)% | ||
Brokerage and clearance fees | — | (2) | (79.5)% | ||
U.S. Equity Derivative Trading Revenues, net | $120 | $108 | 10.7% | ||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Total industry average daily volume (in millions) | 62.6 | 53.6 | |
Nasdaq PHLX matched market share | 12.5% | 9.1% | |
The Nasdaq Options Market matched market share | 2.6% | 5.1% | |
Nasdaq Texas Options matched market share | 1.3% | 1.7% | |
Nasdaq ISE Options matched market share | 6.0% | 6.8% | |
Nasdaq GEMX Options matched market share | 3.4% | 3.6% | |
Nasdaq MRX Options matched market share | 4.3% | 2.8% | |
Total matched market share executed on Nasdaq’s exchanges | 30.1% | 29.1% | |
Three Months Ended March 31, | Percentage Change | ||||
2026 | 2025 | ||||
(in millions) | |||||
Cash Equity Trading Revenues | $548 | $407 | 34.5% | ||
Section 31 fees | — | 234 | (100.0)% | ||
Transaction-based expenses: | |||||
Transaction rebates | (404) | (280) | 44.4% | ||
Section 31 fees | — | (234) | (100.0)% | ||
Brokerage and clearance fees | (6) | (6) | (20.3)% | ||
Cash equity trading revenues, net | $138 | $121 | 14.8% | ||
Three Months Ended March 31, | |||
Total U.S.-listed securities | 2026 | 2025 | |
Total industry average daily share volume (in billions) | 20.0 | 15.7 | |
Matched share volume (in billions) | 183.7 | 137.6 | |
The Nasdaq Stock Market matched market share | 14.7% | 14.2% | |
Nasdaq Texas matched market share | 0.3% | 0.3% | |
Nasdaq PSX matched market share | 0.1% | 0.1% | |
Total matched market share executed on Nasdaq’s exchanges | 15.1% | 14.6% | |
Market share reported to the FINRA/ Nasdaq Trade Reporting Facility | 45.6% | 48.1% | |
Total market share | 60.7% | 62.7% | |
Nasdaq Nordic and Nasdaq Baltic securities | |||
Average daily number of equity trades executed on Nasdaq’s exchanges | 797,886 | 789,103 | |
Total average daily value of shares traded (in billions) | $6.8 | $5.4 | |
Total market share executed on Nasdaq’s exchanges | 74.3% | 70.5% | |
Three Months Ended March 31, | Percentage Change | ||||
2026 | 2025 | ||||
(in millions) | |||||
U.S. Tape plans | $33 | $33 | 1.5% | ||
Three Months Ended March 31, | Percentage Change | ||||
2026 | 2025 | ||||
(in millions) | |||||
Other | $26 | $19 | 30.7% | ||
Three Months Ended March 31, | Percentage Change | ||||
2026 | 2025 | ||||
(in millions) | |||||
Compensation and benefits | $356 | $329 | 8.4% | ||
Professional and contract services | 39 | 36 | 8.5% | ||
Technology and communication infrastructure | 84 | 77 | 8.0% | ||
Occupancy | 33 | 28 | 15.8% | ||
General, administrative and other | 29 | 6 | 458.3% | ||
Marketing and advertising | 20 | 14 | 42.2% | ||
Depreciation and amortization | 165 | 156 | 6.0% | ||
Regulatory | 9 | 15 | (35.7)% | ||
Merger and strategic initiatives | 4 | 24 | (84.7)% | ||
Restructuring charges | 11 | 5 | 103.4% | ||
Total operating expenses | $750 | $690 | 8.8% | ||
Three Months Ended March 31, | Percentage Change | ||||
2026 | 2025 | ||||
(in millions) | |||||
Interest income | $6 | $11 | (48.5)% | ||
Interest expense | (87) | (96) | (10.1)% | ||
Net interest expense | (81) | (85) | (5.1)% | ||
Net gain on divestitures | 89 | — | 100.0% | ||
Other losses | (14) | (1) | NM | ||
Net income from unconsolidated investees | 26 | 27 | (3.2)% | ||
Total non-operating income (expense) | $20 | $(59) | (134.2)% | ||
Three Months Ended March 31, | Percentage Change | ||||
2026 | 2025 | ||||
(in millions) | |||||
Interest expense on debt | $84 | $92 | (10.0)% | ||
Accretion of debt issuance costs and debt discount | 2 | 3 | (13.8)% | ||
Other fees | 1 | 1 | (10.0)% | ||
Interest expense | $87 | $96 | (10.1)% | ||
Three Months Ended March 31, | Percentage Change | ||||
2026 | 2025 | ||||
($ in millions) | |||||
Income tax provision | $158 | $93 | 69.6% | ||
Effective tax rate | 23.4% | 19.1% | |||
Three Months Ended March 31, | |||
2026 | 2025 | ||
(in millions, except per share amounts) | |||
U.S. GAAP net income | $519 | $395 | |
Non-GAAP adjustments: | |||
Amortization expense of acquired intangible assets | 121 | 122 | |
Merger and strategic initiatives expense | 4 | 24 | |
Restructuring charges | 11 | 5 | |
Gain on extinguishment of debt | — | (19) | |
Net gain on divestitures | (89) | — | |
Net income from unconsolidated investees | (26) | (27) | |
Legal and regulatory matters | 6 | 2 | |
Other loss | 15 | 1 | |
Total non-GAAP adjustments | $42 | $108 | |
Total non-GAAP tax adjustments | (12) | (28) | |
Other tax adjustments | — | (19) | |
Total non-GAAP adjustments, net of tax | $30 | $61 | |
Non-GAAP net income | $549 | $456 | |
U.S. GAAP effective tax rate | 23.4% | 19.1% | |
Total adjustments from non- GAAP tax rate | 0.3% | 4.4% | |
Non-GAAP effective tax rate | 23.7% | 23.5% | |
Weighted-average common shares outstanding for diluted earnings per share | 571.7 | 580.0 | |
U.S. GAAP diluted earnings per share | $0.91 | $0.68 | |
Total adjustments from non- GAAP net income | 0.05 | 0.11 | |
Non-GAAP diluted earnings per share | $0.96 | $0.79 | |
March 31, 2026 | December 31, 2025 | |||
(in millions) | ||||
Working capital | $(17) | $42 | ||
Cash and cash equivalents | 515 | 604 | ||
Financial investments | 184 | 28 | ||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Net cash provided by (used in): | (in millions) | ||
Operating activities | $689 | $663 | |
Investing activities | 747 | (258) | |
Financing activities | (4,184) | (1,083) | |
2026 | 2025 | ||
First quarter | $0.27 | $0.24 |

Euro | Swedish Krona | Canadian Dollar | Other Foreign Currencies | U.S. Dollar | |
(in millions, except currency rate) | |||||
Three Months Ended March 31, 2026 | |||||
Average FX rate to the U.S. dollar | 1.171 | 0.110 | 0.729 | # | N/A |
Percentage of revenues less transaction- based expenses | 7.2% | 3.7% | 0.7% | 3.9% | 84.5% |
Percentage of operating income | 9.2% | (1.5)% | (5.5)% | (6.3)% | 104.1% |
Impact of a 10% adverse currency fluctuation on revenues less transaction- based expenses | $(10) | $(5) | $(1) | $(5) | $— |
Impact of a 10% adverse currency fluctuation on operating income | $(6) | $(1) | $(4) | $(4) | $— |
Net Assets | Impact of a 10% Adverse Currency Fluctuation | |||
(in millions) | ||||
Swedish Krona | $3,301 | $(330) | ||
Norwegian Krone | 218 | (22) | ||
Canadian Dollar | 140 | (14) | ||
Australian Dollar | 89 | (9) | ||
British Pound | 84 | (8) | ||
Period | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in millions) | ||||
January 2026 | ||||||||
Share repurchase program | 2,094,972 | $90.78 | 2,094,972 | $939 | ||||
Employee transactions | — | $— | N/A | N/A | ||||
February 2026 | ||||||||
Share repurchase program | 3,914,850 | $84.77 | 3,914,850 | $2,910 | ||||
Employee transactions | — | $— | N/A | N/A | ||||
March 2026 | ||||||||
Share repurchase program | 308,992 | $83.02 | 308,992 | $2,884 | ||||
Employee transactions | — | $— | N/A | N/A | ||||
Total Quarter Ended March 31, 2026 | ||||||||
Share repurchase program | 6,318,814 | $86.67 | 6,318,814 | $2,884 | ||||
Employee transactions | — | $— | N/A | N/A | ||||
Exhibit Number | ||
101 | The following materials from the Nasdaq, Inc. Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025; (ii) Condensed Consolidated Statements of Income for the three months ended March 31, 2026 and 2025; (iii) Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2026 and 2025; (iv) Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three months ended March 31, 2026 and 2025; (v) Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2026 and 2025; and (vi) notes to condensed consolidated financial statements. | |
104 | Cover Page Interactive Data File, formatted in iXBRL and contained in Exhibit 101. |
Nasdaq, Inc. | ||
(Registrant) | ||
By: | /s/ Adena T. Friedman | |
Name: | Adena T. Friedman | |
Title: | Chief Executive Officer | |
Date: | April 24, 2026 | |
By: | /s/ Sarah Youngwood | |
Name: | Sarah Youngwood | |
Title: | Executive Vice President and Chief Financial Officer | |
Date: | April 24, 2026 | |
| /s/ Adena T. Friedman | |||||||||||
| Name: | Adena T. Friedman | ||||||||||
| Title: | Chief Executive Officer | ||||||||||
/s/ Sarah Youngwood | |||||||||||
| Name: | Sarah Youngwood | ||||||||||
| Title: | Executive Vice President and Chief Financial Officer | ||||||||||
| /s/ Adena T. Friedman | |||||||||||
| Name: | Adena T. Friedman | ||||||||||
| Title: | Chief Executive Officer | ||||||||||
| Date: | April 24, 2026 | ||||||||||
/s/ Sarah Youngwood | |||||||||||
| Name: | Sarah Youngwood | ||||||||||
| Title: | Executive Vice President and Chief Financial Officer | ||||||||||
| Date: | April 24, 2026 | ||||||||||